Sonendo Strengthens Leadership With Key Strategic Appointments 
HealingMaps Unveils AI-Powered Chatbot in Collaboration with Vellum.AI
Innovative AI Tool Connects Users to Psychedelic-Assisted Therapy InformationMiami, Florida--(Newsfile Corp. - April 24, 2024) - HealingMaps, a premier directory...
Psirenity Health and Pickleball Ontario Sign a Three-Year Partnership
Psirenity Health will be the Official "Wellness Partner" of Pickleball OntarioOakville, Ontario--(Newsfile Corp. - April 24, 2024) - Psirenity Health...
Moderna and OpenAI Collaborate To Advance mRNA Medicine
Generative AI will help advance Moderna's broad and diverse portfolio to maximize the Company's impact on patientsModerna embeds OpenAI's generative...
Dr. Amir Bajoghli Receives Top Doctor Award 2024 in Dermatology by Northern Virginia Magazine
MCLEAN, VA / ACCESSWIRE / April 24, 2024 / MCLEAN, VA / ACCESSWIRE / April 24, 2022 / Dr. Bajoghli...
Vytalize Health Announces Key Leadership Additions to Support Continued Excellence in Value-Based Care
New CIO, CFO & SVP of Clinical Performance join one of the nation's leading provider enablement platforms with a focus...
Clearstep Partners with Ochsner Health to Tackle Healthcare Access and Capacity Challenges
Leveraging advanced AI technology, the collaboration aims to improve care routing for more than 1.5 million patients CHICAGO, IL /...
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Organizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costsTogether with GSK, ended Pandemic...
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Mr. Ramanayake brings more than fifteen years of experience in biopharma company development and deal-makingStrong track record of successful clinical...
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1)...
Senzime publishes annual and sustainability report for 2023
UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ) announces today that the company's annual...
Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement
TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage...
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
Private Placement of $8.4 million has closed and will fund the commercial development of lead product AVERSA Fentanyl to NDA...
Novo Nordisk A/S – Articles of Association, April 2024
Novo Nordisk's Articles of Association, April 2024 Attachment Articles of Association 24 Apr 2024
Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt
KELOWNA, BC / ACCESSWIRE / April 24, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF) is pleased to...
TVM Capital Healthcare Announces EUR 16 Million Investment into neurocare
neurocare is revolutionizing mental health care by providing innovative methods and tools based on neurostimulation and other technologies to help...
NeuroNexus is Leveraging Bioz’s AI-Powered Citation Tools to Drive Increased Sales Conversion
PALO ALTO, CA / ACCESSWIRE / April 24, 2024 / Bioz, Inc., a Silicon Valley AI company, has partnered with...
Senzime Wins Another Major US Veterans Affairs Contract; Expands Reach of TetraGraph System
UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in perioperative precision-based patient monitoring...
Spago Nanomedical Reports Favorable Data in Breast Cancer Model with Tumorad
LUND, SWEDEN / ACCESSWIRE / April 24, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today data from...
Angle PLC Announces New Commercial Agreement with AstraZeneca
ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D GUILDFORD, SURREY / ACCESSWIRE...
Interim Report January-March 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / April 24, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2024 (Jan 1 - Mar 31)•...